Oud-Heverlee, Belgium

Annemieke Verstuyf



Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Annemieke Verstuyf: Innovator in Pharmaceutical Compositions

Introduction

Annemieke Verstuyf is a notable inventor based in Oud-Heverlee, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of vitamin D analogues and other innovative compounds. With a total of 3 patents, her work has the potential to impact the treatment of various bone disorders.

Latest Patents

One of her latest patents focuses on novel vitamin D analogues that are useful for creating pharmaceutical compositions aimed at preventing or treating bone disorders such as osteoporosis. Another significant invention is related to 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes. This patent encompasses compositions that include these compounds and outlines methods for treating diseases and illnesses using them.

Career Highlights

Annemieke Verstuyf has worked with esteemed institutions such as K.U. Leuven Research & Development and Universiteit Gent. Her research and innovations have garnered attention in the scientific community, showcasing her expertise and dedication to advancing pharmaceutical science.

Collaborations

Throughout her career, Annemieke has collaborated with notable professionals in her field, including Roger Bouillon and Pierre Jean De Clercq. These partnerships have contributed to her success and the development of her innovative ideas.

Conclusion

Annemieke Verstuyf stands out as a pioneering inventor in the pharmaceutical industry. Her contributions, particularly in the realm of vitamin D analogues, highlight her commitment to improving health outcomes. Her work continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…